StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report released on Sunday morning. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
NYSE:AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $1.74. The firm has a market cap of $2,383.50, a P/E ratio of 0.00 and a beta of 3.78.
About Ampio Pharmaceuticals
Read More
- Five stocks we like better than Ampio Pharmaceuticals
- What Are Earnings Reports?
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- How to find penny stocks to invest and tradeĀ
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- Growth Stocks: What They Are, What They Are Not
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.